Skip to main content
Global Site Support | Clinical Trial Imaging Assistance | IXICO
Follow us
✕
Company
Mission
About IXICO
IXI™ Platform
The Power of Neuroimaging
Customers
Partnerships
Leadership Team
Advisors
Careers
Recruitment privacy notice
IXI™ Platform
AI-Driven Insights
Platform Features
Platform Evolution
Services
Imaging Biomarker
Radiological reads
Volumetric MRI
PET & SPECT
Advanced MRI
Trial Management
Data Analytics
Post-Marketing Surveillance
Consultancy
Therapeutic Expertise
Alzheimer's Disease (AD)
Huntington's Disease (HD)
Parkinson's Disease (PD)
Multiple Sclerosis (MS)
Other Rare Neurological Diseases
News & Resources
News
Scientific Publications
Webinars
Downloads
Blog
Investors
Share Price
Governance
AIM Rule 26
Our Board
Oversight
Contacts & Advisers
Investor Resources
Company Documents
Financial Calendar
Investor Presentations
Investor Videos
RNS News
Regulatory Email Alert
Shareholder Info
Contact Us
Submit RFP
Contact Us
Global Site Support
\
News & Resources
News & Resources
Sources
News
Scientific Publications
Webinars
Downloads
Blog
Sources
News
Scientific Publications
Webinars
Downloads
Blog
26 Feb 26
news
IXICO further validates the automation capabilities of its IXI™ neuroimaging technology platform
Read more
25 Feb 26
publications
Further validation of IXI technology platform automation capabilities
Read more
17 Feb 26
blog
Advancing a Multimodal Future for Alzheimer’s Disease Diagnosis
Read more
17 Feb 26
blog
Multi-biomarker assessment to better understand clinical dementia symptoms
Read more
12 Feb 26
news
c.£1.5 million contract extension on global Phase 2 clinical trial
Read more
5 Feb 26
news
IXICO appoints Chief Commercial Officer to accelerate business development activity
Read more
3 Feb 26
publications
Interchangeability of blood-based biomarkers and PET to identify Alzheimer's disease pathology
Read more
28 Jan 26
publications
Biomarkers in patients with clinical signs of mild cognitive impairment or mild Alzheimer's disease
Read more
14 Jan 26
publications
Agreement Between Amyloid Status Prediction from Visual Read, SUVR Thresholding
Read more
13 Jan 26
blog
Advancing Amyloid Assessment in PET Imaging: Integrating AI with Quantitative Metrics
Read more
8 Dec 25
news
Financial Results for year ended 30 September 2025 and Notice of AGM
Read more
4 Dec 25
publications
AI-Driven Recruitment for AD Clinical Trials A Pilot Analysis on the A4 Study Dataset
Read more
1
2
3
4
...
13
Prev
Next
13 - 24 of 146 results
Ixico News on Proactive
IXICO guidance unchanged after Huntington's cancellations
July 13th 2026 06:37 AM
IXICO lifts revenue forecast on contract wins and wider client base - UPDATE
July 7th 2026 09:10 AM
IXICO strengthens Alzheimer's and Parkinson's advisory board with world-class experts
June 8th 2026 13:55 PM
IXICO expands scientific network in Alzheimer’s and Parkinson’s disease
June 8th 2026 06:26 AM
Bram Goorden discusses IXICO growth plans - ICYMI
May 24th 2026 06:50 AM
IXICO contract wins provide near-total revenue visibility for current year
May 21st 2026 10:45 AM
IXICO, Ilika, EMV Capital, Zephyr Energy, Metals One, Bradda Head Lithium - Small Cap Snapshot
May 21st 2026 08:25 AM
IXICO wins £1.3 million in Alzheimer's and Huntington's contracts
May 21st 2026 06:21 AM
Cavendish sees IXICO forecasts as conservative after order book hits five-year high
May 19th 2026 10:00 AM
IXICO reports strong H1 revenue growth as Alzheimer’s trial demand accelerates
May 19th 2026 06:15 AM
IXICO targets 15% revenue growth as order book swells and strategy takes shape
May 19th 2026 06:11 AM
IXICO launches latest version of AI neuroimaging platform
May 12th 2026 06:21 AM
IXICO boss says Medidata collab is poster child of partnership plans - ICYMI
April 25th 2026 06:45 AM
IXICO CEO on growth, margins & TechBio strategy
April 21st 2026 08:50 AM
Cavendish sees significant upside in IXICO as surging order book and £10m raise point to growth inflexion
April 21st 2026 08:22 AM
Updated: 7 minute 53 seconds ago
Sign-up to the latest from IXICO
